Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:TORC

resTORbio (TORC) Stock Price, News & Analysis

resTORbio logo

About resTORbio Stock (NASDAQ:TORC)

Key Stats

Today's Range
$0.91
$0.98
50-Day Range
$2.28
$14.77
52-Week Range
$0.86
$10.50
Volume
842,490 shs
Average Volume
1.15 million shs
Market Capitalization
$33.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Adicet Bio, Inc. is a biotechnology company which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Receive TORC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for resTORbio and its competitors with MarketBeat's FREE daily newsletter.

TORC Stock News Headlines

Adicet Bio Inc (ACET)
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
TinOne Resources Inc. (TORC.V)
See More Headlines

TORC Stock Analysis - Frequently Asked Questions

resTORbio, Inc. (NASDAQ:TORC) posted its quarterly earnings data on Thursday, July, 30th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.07.

resTORbio (TORC) raised $86 million in an IPO on Friday, January 26th 2018. The company issued 5,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Leerink Partners and Evercore ISI served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that resTORbio investors own include Novavax (NVAX), VBI Vaccines (VBIV), AbbVie (ABBV), Dynavax Technologies (DVAX), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
7/30/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TORC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-82,740,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.24 per share

Miscellaneous

Free Float
N/A
Market Cap
$33.32 million
Optionable
Not Optionable
Beta
2.43
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NASDAQ:TORC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners